Researchers at the 47th Society of Critical Care Medicine reported this week that Hill-Rom‘s (NYSE:HRC) Metaneb System may help reduce the incidence of post-operative pulmonary complications in high-risk patients. A 419-patient study found that patients using the Metaneb System combined with standard respiratory therapy spent 1.6 fewer days in the hospital on average compared to the […]
Surgical
Wright Medical turns a $29 million profit in Q4, sales up 12.7%
Wright Medical (NSDQ:WMGI) today made good on its previously predicted 12.7% increase in fourth-quarter sales, boosted by a 29% jump in U.S. sales of its upper extremity surgical solutions for the shoulder, elbow, wrist and hand. The earnings results, reported after market close, included sales of $217.6 million for the quarter ended Dec. 31. Profits were $29.1 […]
Integra Lifesciences reports Street-beating earnings, stock still down
Integra Lifesciences (Nasdaq: IART) today reported fourth-quarter and full-year results that beat analysts expectations, but its stock is still down slightly — perhaps because its gross margins were down as it digests more than $1.2 billion worth of acquisitions. CEO Peter J. Arduini during an earnings call ticked off the Plainsboro, N.J.–based surgical and medical instruments […]
AtriCure beats the Street during Q4, analysts predict ‘growth acceleration’
AtriCure (Nasdaq: ATRC) — an innovator in treatments for atrial fibrillation and left atrial appendage management — is enjoying a rise in its stock value today after releasing results that beat the Street. Mason, Ohio–based AtriCure’s stock was up 67 cents per share, or 3.7%, closing at $18.99. The company reported yesterday evening that it revenue for […]
B. Braun’s Aesculap closes $17m Dextera Surgical bankruptcy buyout
Surgical instrument maker Dextera Surgical and B. Braun subsidiary Aesculap said yesterday that they closed the $17.3 million deal to buy Dextera out of Chapter 11 bankruptcy. Redwood City, Calif.- based Dextera, formerly known as Cardica, agreed to the buyout in December 2017. The consummation Feb. 20 saw Dextera receive $13.6 million; another $2 million went into two-year escrow, $900,000 went to repay […]
Paragonix Tech wins CE Mark for heart transport devices
Paragonix Technologies said today it won CE Mark approval in the European Union for its SherpaPak and SherpaPerfusion cardiac transport systems. The SherpaPak system consists of a single-use, disposable device designed for the hypothermic static preservation and transportation of the donor hearts, while the SherpaPerfusion system is a single-use, disposable device designed for hypothermic oxygenated […]
Corindus wins FDA 510(k) PVI indication for CorPath GRX
Corindus Vascular Robotics (OTC:CVRS) said today it won FDA 510(k) clearance for its CorPath GRX system, now indicated for use in peripheral vascular interventions. The Waltham, Mass.-based company touts the CorPath system as the first and only FDA-cleared robotic device cleared for both percutaneous coronary interventions and peripheral vascular interventions. “My colleagues and I have seen first-hand […]
Titan Medical touts hitting all milestones in 2017 financial results
Titan Medical (TSX:TMD) late yesterday released its full year 2017 financial results, touting that it met all its milestones during the year and that its Sport system was used in the first single-port procedures. The Toronto-based company reported research and development expenses of $12.9 million for the year, down from $22.6 million the company spent the […]
TransEnterix files expanded 510(k) application for Senhance robotic platform
TransEnterix (NYSE:TRXC) said today it filed an FDA 510(k) submission looking to expand the indications for its Senhance robotic surgical platform to include laparoscopic inguinal hernia and laparoscopic cholecystectomy surgeries. The Research Triangle Park, N.C.-based company said that with the additional indications, its Senhance system would be cleared for use in the most common abdominal surgeries in […]
Icon Bioscience wins FDA nod for long-acting cataract surgery drug
Icon Bioscience said today that the FDA has approved its application for Dexycu, a long-acting therapy designed to treat inflammation in patients who have had cataract surgery. More than four million cataract surgeries are performed each year in the U.S., according to the privately-held biopharma company, and most patients treat inflammation in their eyes using medicated […]
Bard escapes hernia mesh lawsuit
Becton Dickinson & Co.‘s (NYSE:BDX) C.R. Bard (NYSE:BCR) and subsidiary Davol this week avoided a lawsuit over allegedly defective hernia meshes after an appellate panel reaffirmed a lower court’s dismissal. The lower court had dismissed the suit on the grounds that the operating physician in the case was informed of risks associated with the mesh, eliminating […]